CVS Health Corporation (ETR:CVS)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of EUR 87.97 billion. The enterprise value is 148.95 billion.

Market Cap	87.97B
Enterprise Value	148.95B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Oct 23, 2025

Share Statistics

Current Share Class	1.27B
Shares Outstanding	n/a
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.62%
Float	1.27B

Valuation Ratios

The trailing PE ratio is 220.09 and the forward PE ratio is 11.53.

PE Ratio	220.09
Forward PE	11.53
PS Ratio	0.26
PB Ratio	1.41
P/TBV Ratio	n/a
P/FCF Ratio	16.40
P/OCF Ratio	11.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 27.77.

EV / Earnings	372.62
EV / Sales	0.44
EV / EBITDA	9.76
EV / EBIT	17.02
EV / FCF	27.77

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.12.

Current Ratio	0.83
Quick Ratio	0.59
Debt / Equity	1.12
Debt / EBITDA	4.62
Debt / FCF	12.99
Interest Coverage	3.28

Financial Efficiency

Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	0.58%
Return on Assets (ROA)	2.50%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	6.24%
Revenue Per Employee	1.29M
Profits Per Employee	1,540
Employee Count	300,000
Asset Turnover	1.54
Inventory Turnover	18.54

Taxes

In the past 12 months, CVS Health has paid 2.11 billion in taxes.

Income Tax	2.11B
Effective Tax Rate	85.28%

Stock Price Statistics

The stock price has increased by +22.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+22.02%
50-Day Moving Average	67.72
200-Day Moving Average	60.90
Relative Strength Index (RSI)	55.98
Average Volume (20 Days)	246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, CVS Health had revenue of EUR 333.84 billion and earned 399.73 million in profits. Earnings per share was 0.32.

Revenue	333.84B
Gross Profit	44.58B
Operating Income	8.65B
Pretax Income	2.48B
Net Income	399.73M
EBITDA	12.57B
EBIT	8.65B
Earnings Per Share (EPS)	0.32

Balance Sheet

The company has 9.57 billion in cash and 69.68 billion in debt, giving a net cash position of -60.10 billion.

Cash & Cash Equivalents	9.57B
Total Debt	69.68B
Net Cash	-60.10B
Net Cash Per Share	n/a
Equity (Book Value)	62.31B
Book Value Per Share	48.94
Working Capital	-13.28B

Cash Flow

In the last 12 months, operating cash flow was 7.76 billion and capital expenditures -2.40 billion, giving a free cash flow of 5.36 billion.

Operating Cash Flow	7.76B
Capital Expenditures	-2.40B
Free Cash Flow	5.36B
FCF Per Share	n/a

Margins

Gross margin is 13.35%, with operating and profit margins of 2.59% and 0.12%.

Gross Margin	13.35%
Operating Margin	2.59%
Pretax Margin	0.74%
Profit Margin	0.12%
EBITDA Margin	3.77%
EBIT Margin	2.59%
FCF Margin	1.61%

Dividends & Yields

This stock pays an annual dividend of 2.36, which amounts to a dividend yield of 3.41%.

Dividend Per Share	2.36
Dividend Yield	3.41%
Dividend Growth (YoY)	-4.12%
Years of Dividend Growth	3
Payout Ratio	746.07%
Buyback Yield	0.37%
Shareholder Yield	3.78%
Earnings Yield	0.45%
FCF Yield	6.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6